Back
Leap Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
44
LPTX
Leap Therapeutics
Last Price:
2.74
Seasonality Move:
-8.32%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
273.83
Seasonality Move:
5.61%
Sell
44
Leap Therapeutics (LPTX)
is a Sell
Is Leap Therapeutics a Buy, Sell or Hold?
- The current Leap Therapeutics [LPTX] share price is $2.84. The Score for LPTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- LPTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $276.33. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LPTX Stock Price Chart
What is Leap Therapeutics's stock price today?
-
The Leap Therapeutics share price today is $2.84
The current trend is moderately bearish and LPTX is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $276.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
LPTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 54.67 | Buy |
| Chaikin Money Flow: | -36388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.67 - 2.93) | Buy |
| Bollinger Bands (100): | (2.04 - 2.84) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 60.54 | Buy |
| Chaikin Money Flow: | -66637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.89 - 278.47) | Buy |
| Bollinger Bands (100): | (164.63 - 269.71) | Buy |
LPTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.83 | Buy |
| 20-day SMA: | 2.84 | Buy |
| 50-day SMA: | 2.5 | Buy |
| 200-day SMA: | 2.74 | Buy |
| 8-day EMA: | 2.85 | Sell |
| 20-day EMA: | 2.78 | Buy |
| 50-day EMA: | 2.6 | Buy |
| 200-day EMA: | 2.74 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 267.42 | Buy |
| 20-day SMA: | 266.35 | Buy |
| 50-day SMA: | 259.79 | Buy |
| 200-day SMA: | 191.66 | Buy |
| 8-day EMA: | 269.14 | Buy |
| 20-day EMA: | 265.86 | Buy |
| 50-day EMA: | 253.52 | Buy |
| 200-day EMA: | 208.02 | Buy |
Leap Therapeutics Earnings Growth & LPTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.13 per share, an increase this year of $1.53 per share, and an increase next year of $0.54 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Leap Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||